01 3Testopel
02 2Voltaren
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2020 Revenue in Millions : 35
2019 Revenue in Millions : 55
Growth (%) : -36
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2021 Revenue in Millions : 44
2020 Revenue in Millions : 35
Growth (%) : 24
Main Therapeutic Indication : Bone and Joint Diseases
Currency : USD
2017 Revenue in Millions : 69
2016 Revenue in Millions : 101
Growth (%) : -32
Main Therapeutic Indication : Bone And Joint Diseases
Currency : USD
2018 Revenue in Millions : 58
2017 Revenue in Millions : 69
Growth (%) : -16%
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2019 Revenue in Millions : 55
2018 Revenue in Millions : 58
Growth (%) : -5
LOOKING FOR A SUPPLIER?